---
title: "China Shineway Pharmaceutical Declares First Interim Dividend for Fiscal 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280729845.md"
description: "China Shineway Pharmaceutical Declares First Interim Dividend for Fiscal 2026"
datetime: "2026-03-27T04:55:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280729845.md)
  - [en](https://longbridge.com/en/news/280729845.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280729845.md)
---

# China Shineway Pharmaceutical Declares First Interim Dividend for Fiscal 2026

China Shineway Pharmaceutical Declares First Interim Dividend for Fiscal 2026

### Related Stocks

- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [02877.HK](https://longbridge.com/en/quote/02877.HK.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Shanghai Henlius says China regulator clears HLX48 Phase 1 trial IND for solid tumors](https://longbridge.com/en/news/287189347.md)
- [Shanghai Henlius wins Australia clearance to start Phase 1 HLX3902 cancer trial](https://longbridge.com/en/news/287190785.md)
- [SSY Group wins China NMPA approval for emedastine difumarate eye drops 0.05%](https://longbridge.com/en/news/287187916.md)